AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.700
-0.190 (-6.57%)
Mar 27, 2026, 4:00 PM EDT - Market closed

AC Immune Balance Sheet

Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
26.836.2878.4931.5982.22
Short-Term Investments
64.62129.2124.5591116
Cash & Short-Term Investments
91.41165.49103.05122.59198.22
Cash Growth
-44.76%60.59%-15.94%-38.16%-12.25%
Accounts Receivable
--14.8--
Other Receivables
0.981.10.620.390.43
Total Trade Receivables
0.981.115.420.390.43
Other Current Assets
4.335.46.685.123.99
Total Current Assets
96.72171.99125.15128.09202.63
Net Property, Plant & Equipment
6.538.096.887.078.03
Other Intangible Assets
50.4250.4250.4250.4250.42
Long-Term Investments
0.580.420.360.360.36
Total Assets
154.25230.91182.81185.94261.44
Accrued Expenses
8.0712.111.099.4216.74
Current Portion of Leases
0.851.030.670.550.57
Unearned Revenue
83.7185.060.140.590.72
Other Current Liabilities
2.072.661.680.932
Total Current Liabilities
94.69100.8413.5811.4820.03
Long-Term Leases
3.694.42.832.252.34
Other Long-Term Liabilities
10.9913.45.773.217.1
Total Long-Term Liabilities
14.6717.818.65.479.44
Total Liabilities
109.37118.6422.1716.9529.46
Common Stock
2.252.232.091.81.79
Treasury Stock
-0.22-0.22-0.11-0.12-0.12
Additional Paid-in Capital
481.86478.51474.91431.32431.25
Accumulated Other Comprehensive Income
0.01-0.01-0.05--
Retained Earnings
-439.02-368.24-316.2-264.02-200.94
Shareholders' Equity
44.88112.27160.64168.99231.98
Total Liabilities & Equity
154.25230.91182.81185.94261.44
Total Debt
4.545.433.52.82.91
Net Cash (Debt)
86.87160.0699.55119.79195.31
Net Cash Growth
-45.73%60.78%-16.89%-38.67%-12.68%
Net Cash Per Share
0.861.611.18-2.61
Book Value
44.88112.27160.64168.99231.98
Book Value Per Share
0.451.131.90-3.10
Tangible Book Value
-5.5361.85110.23118.58181.56
Tangible Book Value Per Share
-0.050.621.30-2.42
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q